4.7 Article

AcquaAlta: A Directional Approach to the Solvation of Ligand-Protein Complexes

Journal

JOURNAL OF CHEMICAL INFORMATION AND MODELING
Volume 51, Issue 8, Pages 1867-1881

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/ci200150p

Keywords

-

Funding

  1. Swiss National Foundation [200021_119817]
  2. Swiss National Science Foundation (SNF) [200021_119817] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

Water molecules mediating polar interactions in ligand protein complexes can substantially contribute to binding affinity and specificity. To account for such water molecules in computer-aided drug design, we performed an extensive search in the Cambridge Structural Database (CSD) to identify the geometrical criteria defining interactions of water molecules with ligand and protein. In addition, with ab initio calculations the propensity of ligand hydration was evaluated. Based on this information, we developed an algorithm (AcquaAlta) to reproduce water molecules bridging polar interactions between ligand and protein moieties. This approach was validated with 20 crystal structures and yielded a match of 76% between experimental and calculated water positions. When water molecules establishing only weak interactions with the protein were neglected, the match could be improved to 88%. Supported by a pharmacophore-based alignment tool, the solvation algorithm was then applied to the docking of oligopeptides to the periplasmic oligopeptide binding protein A (OppA). Calculated waters based on the crystal poses matched an average of 66% of the experimental waters. With water molecules calculated based on the docked ligands, the average match with the experimental waters dropped to 53%.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds

Andre Fischer, Manuel Sellner, Santhosh Neranjan, Martin Smiesko, Markus A. Lill

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Pharmacology & Pharmacy

In Silico Pharmacogenetics CYP2D6 Study Focused on the Pharmacovigilance of Herbal Antidepressants

Charleen G. Don, Martin Smiesko

FRONTIERS IN PHARMACOLOGY (2020)

Article Plant Sciences

Compounds from Toddalia asiatica: Immunosuppressant Activity and Absolute Configurations

Jakob K. Reinhardt, Amy M. Zimmermann-Klemd, Ombeline Danton, Martin Smiesko, Carsten Gruendemann, Matthias Hamburger

JOURNAL OF NATURAL PRODUCTS (2020)

Article Biochemistry & Molecular Biology

Conformational Landscape of Cytochrome P450 Reductase Interactions

Manuel Sellner, Andre Fischer, Charleen G. Don, Martin Smiesko

Summary: Research using molecular dynamics simulations and protein-protein docking revealed the mechanism of conformational changes between cytochrome P450 enzymes and cytochrome P450 reductase, as well as proposed new conformational transition mechanisms and structural mechanisms for susceptibility to redox states.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Chemistry, Medicinal

Conformational Changes of Thyroid Receptors in Response to Antagonists

Andre Fischer, Gabriela Frehner, Markus A. Lill, Martin Smiesko

Summary: Thyroid hormone receptors (TRs) are crucial for human development, growth, and metabolism, and antagonists of TRs can effectively treat hyperthyroidism. Computational methods such as MD simulations provide valuable insights into ligand-induced conformational changes in nuclear receptors, which can be important for the development of novel therapeutics.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)

Article Biochemistry & Molecular Biology

Computational Selectivity Assessment of Protease Inhibitors against SARS-CoV-2

Andre Fischer, Manuel Sellner, Karolina Mitusinska, Maria Bzowka, Markus A. Lill, Artur Gora, Martin Smiesko

Summary: Research assessed the selectivity of 33 reported non-covalent inhibitors of SARS-CoV-2 M-pro against eight proteases and 16 anti-targets, revealing off-target binding of some compounds to multiple proteases and anti-targets, with a high risk especially in chymase and cathepsin G.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Chemistry, Medicinal

Computational Assessment of Combination Therapy of Androgen Receptor-Targeting Compounds

Andre Fischer, Florian Hauptli, Markus A. Lill, Martin Smiesko

Summary: The study found that BF-3 inhibitors are more suitable for combination with classical antiandrogens than AF-2 inhibitors. Classic antiandrogens can cause changes in helix-12 through structural adaptation, accompanied by an expansion of the orthosteric binding site.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)

Article Chemistry, Medicinal

Decision Making in Structure-Based Drug Discovery: Visual Inspection of Docking Results

Andre Fischer, Martin Smiesko, Manuel Sellner, Markus A. Lill

Summary: This study reviewed the medicinal chemistry literature to explore the importance of visual inspection in molecular docking for drug discovery. Through surveys and expert opinions, valuable insights into visually supported decision-making processes were provided.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Pharmacology & Pharmacy

Species-specific differences in the inhibition of 11β-hydroxysteroid dehydrogenase 2 by itraconazole and posaconazole

Silvia G. Inderbinen, Michael Zogg, Manuel Kley, Martin Smiesko, Alex Odermatt

Summary: The study discovered a species-specific inhibition of 11 beta-HSD2 by azole antifungals, with human enzyme being most sensitive, while mouse and zebrafish enzymes showing weak inhibition. Structural differences in the C-terminal region and substrate binding pocket were identified as key factors contributing to the observed differences in sensitivity to the inhibitors. This information could aid in future evaluations of 11 beta-HSD2 inhibitors and in selecting appropriate animal models for efficacy and safety studies.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2021)

Article Biochemistry & Molecular Biology

A Conserved Allosteric Site on Drug-Metabolizing CYPs: A Systematic Computational Assessment

Andre Fischer, Martin Smiesko

Summary: This study investigates an allosteric site in Cytochrome P450 enzymes, finding it to be well conserved in the CYP2 family with the exception of CYP2E1, and observing an enlargement of ligand tunnels in certain members that facilitate ligand translocation. The research contributes to understanding ligand access phenomena and aids in estimating the selectivity of metabolic transformations using computational techniques.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Ligand pathways in estrogen-related receptors

Andre Fischer, Ferhat Bardakci, Manuel Sellner, Markus A. Lill, Martin Smiesko

Summary: ERR alpha, ERR beta, and ERR gamma are nuclear receptors that regulate metabolic processes in various tissues. They have been implicated as drug targets for important indications. This study used molecular dynamics and metadynamics simulations to investigate the ligand pathways of these receptors, revealing their distribution and their role in ligand translocation.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Article Chemistry, Medicinal

Investigation of Thiocarbamates as Potential Inhibitors of the SARS-CoV-2 Mpro

Katarzyna Papaj, Patrycja Spychalska, Katarzyna Hopko, Patryk Kapica, Andre Fisher, Markus A. Lill, Weronika Bagrowska, Jakub Nowak, Katarzyna Szleper, Martin Smiesko, Anna Kasprzycka, Artur Gora

Summary: In this study, a small library of thionocarbamates, thiolocarbamates, sulfide, and disulfide were tested as potential lead compounds for SARS-CoV-2 Mpro drug design using the microscale thermophoresis technique. The identified binder from the thionocarbamates group showed high potential for future modifications to improve affinity and solubility. Computational studies highlighted the inadequacy of simple approaches and the necessity of more advanced methods to properly evaluate the affinity of potential SARS-CoV-2 Mpro binders.

PHARMACEUTICALS (2021)

Article Pharmacology & Pharmacy

Activation of retinoic acid-related orphan receptor γ(t) by parabens and benzophenone UV-filters

Silvia G. Inderbinen, Manuel Kley, Michael Zogg, Manuel Sellner, Andre Fischer, Jacek Kedzierski, Stephanie Boudon, Anton M. Jetten, Martin Smiesko, Alex Odermatt

Summary: ROR gamma t is a key protein that regulates immune responses, and impaired function may contribute to inflammatory and autoimmune diseases and promote skin cancer. Certain chemicals commonly used in cosmetics and body care products have been found to activate ROR gamma t and potentially worsen skin diseases. Further research is needed to assess the concentrations of these compounds in tissues and target cells, and their significance in activating ROR gamma t.

TOXICOLOGY (2022)

Article Environmental Sciences

Evaluating the food safety and risk assessment evidence-base of polyethylene terephthalate oligomers: Protocol for a systematic evidence map

Verena N. Schreier, Christian Appenzeller-Herzog, Beat J. Bruschweiler, Birgit Geueke, Martin F. Wilks, Thomas J. Simat, Benoit Schilter, Martin Smiesko, Jane Muncke, Alex Odermatt, Nicolas Roth

Summary: This article presents a systematic evidence map (SEM) that aims to identify and organize existing knowledge clusters and associated gaps in hazard and exposure information of PET oligomers. The study intends to provide insights for chemical risk assessment and support future toxicity testing strategies and regulatory decision-making regarding PET oligomers.

ENVIRONMENT INTERNATIONAL (2022)

Article Multidisciplinary Sciences

Insight into mode-of-action and structural determinants of the compstatin family of clinical complement inhibitors

Christina Lamers, Xiaoguang Xue, Martin Smiesko, Henri van Son, Bea Wagner, Nadja Berger, Georgia Sfyroera, Piet Gros, John D. Lambris, Daniel Ricklin

Summary: The authors provide molecular-level insight into the mode-of-action, target selectivity, and species specificity of the compstatin family of complement inhibitors, which entered the clinic in 2021.

NATURE COMMUNICATIONS (2022)

No Data Available